Molecular and Cellular Biochemistry

, Volume 276, Issue 1–2, pp 105–111 | Cite as

MCP-1 and MIP-2 expression and production in BB diabetic rat: Effect of chronic hypoxia

  • Cacchio Marisa
  • Isabella Lucci
  • Camillo Di Giulio
  • Giuseppina Bianchi
  • Alfredo Grilli
  • Antonia Patruno
  • Marcella Reale
Article

Abstract

Type 1 (insulin-dependent) diabetes mellitus is an autoimmune disease characterized by the failure to synthesize or secrete insulin, and diabetics are likely to suffer complications that include kidney and heart disease, as well as loss of sight, angiopathy, tissue hypoxia, reduction in organ blood flow, impaired wound healing, respiratory infections, arteriosclerosis, etc., thus diabetes very closely resembles a state of chronic hypoxia. It is now well recognized that hypoxia is an important environmental stimulus capable of modulating the expression of many genes involved in energy metabolism. The diabetic metabolic stress resulting from impaired energy metabolism, which produce altered production of inflammatory mediators, may increase the risk of oxidative injury. The aim was to investigate whether production of MIP-2 and MCP-1 are implicated in the pathogenesis of diabetes, and if the regulatory effects of these chemokines are affected by hypoxia. Two groups of rats, diabetic and non-diabetic, were kept in normoxic room air conditions or subjected to chronic hypoxia. Expression and production of chemokines were measured by RT-PCR and ELISA assay. In diabetic rats, we found a marked increase of MCP-1 when compared with non-diabetic rats (783.5± 49 versus 461.9 ± 27), while no significant differences were detected for MIP-2 levels. Hypoxia selectively modulated chemokines production, since MCP-1 expression and production was up-regulated in the diabetic groups (783.5± 49 versus 461.9 ± 27), but down-regulated MIP-2 expression and production (87.8 ± 23 versus 522.1 ± 72). Our data point to MCP-1 and MIP-2 as important components in the pathophysiology of diabetes, and hypoxia is an important and potent environmental stimulus capable of modulating the expression and production of these chemokines. (Mol Cell Biochem 276: 105–111, 2005)

BB diabetic rat hypoxia mast cells MCP-1 MIP-2 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Baggiolini M: Chemokines and leukocytes traffic. Nature 392: 565–568, 1998CrossRefPubMedGoogle Scholar
  2. 2.
    Baggiolini M, Dewald B, Moser B: Human chemokines: An update. Ann Rev Immunol 15: 675–705, 1997CrossRefGoogle Scholar
  3. 3.
    Luster AD: Chemokines-chemotactic cytokines that mediate inflammation. New Engl J Med 338: 436–445, 1998CrossRefPubMedGoogle Scholar
  4. 4.
    Conti P, Reale M, Barbacane RC, Castellani ML, Orso C: Differential production of RANTES and MCP-1 in synovial fluid from the inflamed human knee. Immunol Lett 80(2): 105–111, 2002CrossRefPubMedGoogle Scholar
  5. 5.
    Cipollone F, Marini M, Fazia M, Pini B, Iezzi A, Reale M, Paloscia L, Materazzo G, D’Annunzio E, Conti P, Chiarelli F, Cuccurullo F, Mezzetti A: Elevated circulating levels of monocyte chemoattractant protein-1 in patients with restenosis after coronary angioplasty. Arterioscler Thromb Vasc Biol 21(3): 327–334, 2001PubMedGoogle Scholar
  6. 6.
    Porreca E, Sergi R, Baccante G, Reale M, Orsini L, Febbo CD, Caselli G, Cuccurullo F, Bertini R: Peripheral blood mononuclear cell production of interleukin-8 and IL-8-dependent neutrophil function in hypercholesterolemic patients. Atherosclerosis 146(2): 345–350, 1999CrossRefPubMedGoogle Scholar
  7. 7.
    Conti P, Barbacane RC, Reale M: Chemokines in inflammatory states. Allergy Asthma Proc 20(4): 205–208, 1999PubMedGoogle Scholar
  8. 8.
    Conti P, Feliciani C, Barbacane RC, Frydas S, Placido FC, Cataldo I, Reale M: Monocyte chemotactic protein-1 gene expression and translation in formed granulomatous calcified tissue in vivo. Calcif Tissue Int 64(1): 57–62, 1999CrossRefPubMedGoogle Scholar
  9. 9.
    Reale M, Intorno R, Tenaglia R, Feliciani C, Barbacane RC, Santoni A, Conti P: Production of MCP-1 and RANTES in bladder cancer patients after bacillus Calmette-Guerin Immunotherapy. Cancer Immunol Immunother 51(2): 91–98, 2002CrossRefPubMedGoogle Scholar
  10. 10.
    Conti P, Pang X, Boucher W, Letourneau R, Reale M, Barbacane RC, Thibault J, Theoharides TC: Impact of RANTES and MCP-1 chemokines on in vivo basophilic cell recruitment in rat skin injection model and their role in modifying the protein and mRNA levels for histidine decarboxylase. Blood 89(11): 4120–4127, 1997PubMedGoogle Scholar
  11. 11.
    Leonard EJ, Yoshimuta T: Human monocyte chemoattractant protein-1 (MCP-1). Immunol Today 11: 97–99, 1990CrossRefPubMedGoogle Scholar
  12. 12.
    Wolpe SD, Sherry B, Juers D, Davatelis G, Yurt RW, Cerami A: Identification and characterization of macrophage inflammatory protein 2. Proc Natl Acad Sci USA 86: 612–616, 1989PubMedGoogle Scholar
  13. 13.
    Tekamp-Olson P, Galegos C, Bauer D, McClain J, Sherry B, Fabre MS, van Deventer S, Cerami A: Cloning and characterization of cDNAs for murine macrophage inflammatory protein 2 and its human homologues. J Exp Med 172: 911–919, 1990CrossRefPubMedGoogle Scholar
  14. 14.
    Bach JF: Insulin-dependent diabetes mellitus as a beta-cell targeted disease of immunomodulation. J Autoimmune 8: 439–463, 1995CrossRefGoogle Scholar
  15. 15.
    Gepts W: Pathologic anatomy of the pancreas in juvenile diabetes mellitus. Diabetes 14: 619–633, 1965PubMedGoogle Scholar
  16. 16.
    Castano L, Eisenbarth GS: Type-I diabetes: A chronic autoimmune disease of human, mouse, and rat. Annu Rev Immunol 8: 647–679, 1990CrossRefPubMedGoogle Scholar
  17. 17.
    Lerman OZ, Galiano RD, Armour M, Levine JP, Gurtner GC: Cellular dysfunction in the diabetic fibroblast: impairment in migration, vascular endothelial growth factor production, an response to hypoxia. Am J Pathol 162: 303–312, 2003PubMedGoogle Scholar
  18. 18.
    Shanmugam N, Reddy MA, Guha M, Natarajan R: High glucose-induced expression of proinflammatory cytokine and chemokine genes in monocytic cells. Diabetes 52: 1256–1264, 2003PubMedGoogle Scholar
  19. 19.
    Ihm CG, Park JK, Hong SP, Lee TW, Cho BS, Kim MJ, Cha DR, Ha H: A high glucose concentration stimulates the expression of monocyte chemotactic peptide 1 in human mesangial cells. Nephron 79: 33–37, 1998CrossRefPubMedGoogle Scholar
  20. 20.
    Norrby K, Arnqvist HJ: Acute hyperglycaemia and mast-cell-dependent mitogenesis in rat. Horm Metab Res 12: 626–629, 1985Google Scholar
  21. 21.
    Ennis M, Trimble ER: Comparison of histamine release from peritoneal mast cells derived from diabetic and control rats. Agents Actions 33: 23–25, 1991CrossRefPubMedGoogle Scholar
  22. 22.
    Bosco MC, Puppo M, Pastorino S, Mi Z, Melillo G, Massazza S, Rapisarda A, Varesio L: Hypoxia selectively inhibits monocyte chemoattractant protein-1 production by macrophages. J Immunol 172(3): 1681–1690, 2004PubMedGoogle Scholar
  23. 23.
    Reale M, Di Giulio C, Cacchio M, Barbacane RC, Grilli A, Felaco M, Bianchi G, Di Gioacchino M, Conti P: Oxygen supply modulates MCP-1 release in monocytes from young and aged rats: decrease of MCP-1 transcription and translation is age-related. Mol Cell Biochem 248(1–2): 1–6, 2003CrossRefPubMedGoogle Scholar
  24. 24.
    Yang B, Houlberg K, Millward A, Demaine A: Polymorphisms of chemokine and chemokine receptor genes in Type 1 diabetes mellitus and its complications. Cytokine 7: 114–121, 2004CrossRefGoogle Scholar
  25. 25.
    Banba N, Nakamura T, Matsumura M, Kuroda H, Hattori Y, Kasai K: Possible relationship of Tumini S, De Cesare D, Pomilio M, Pierdomenico SD, Di Gioacchino M, Cuccurullo F, Mezzetti monocyte chemoattractant protein-1 with diabetic nephropathy. Kidney Int 58: 684–690, 2000CrossRefPubMedGoogle Scholar
  26. 26.
    Vinik A, Vinik E: Prevention of the complications of diabetes. Am J Manag Care 9: S63–S80, 2003PubMedGoogle Scholar
  27. 27.
    Felaco M, Grilli A, Gorbunov N, Di Napoli P, De Lutiis MA, Di Giulio C, Taccardi AA, Barsorri A, Barbacane R, Reale M, Conti P: Endothelial NOS expression and ischemia-reperfusion in isolated working rat heart from hypoxic and hyperoxic conditions. Biochim Biophyis Acta 1524: 203–211, 2000Google Scholar
  28. 28.
    Chiarelli F, Cipollone F, Mohn A, Marini M, Iezzi A, Fazia M: Circulating monocyte chemoattractant protein-1 and early development of nephropathy in Type 1 diabetes. Diabetes Care 25: 1829–1834, 2002PubMedGoogle Scholar
  29. 29.
    Nomura S, Shouzu A, Omoto S, Nishikawa M, Fukuhara S: Significance of chemokines and activated platelets in patients with diabetes. Clin Exp Immunol 121: 437–443, 2000CrossRefPubMedGoogle Scholar
  30. 30.
    Sasaki A: Mortality and cause of death in diabetes mellitus in Japan. Diabetes Res Clin Pract 24: S299–S306, 1994CrossRefPubMedGoogle Scholar
  31. 31.
    Glowacka E, Banasik M, Lewkowicz P, Tchorzewski H: The effect of LPS on neutrophils from patients with high risk of type 1 diabetes mellitus in relation to IL-8, IL-10 and IL-12 production and apoptosis in vitro. Scand J Immuno 55: 210–217, 2002CrossRefGoogle Scholar
  32. 32.
    Steiner DR, Gonzales NC, Wood JG: Mast cells mediate the microvascular inflammatory response systemic hypoxia. J Appl Physiol 94: 325–334, 2003PubMedGoogle Scholar
  33. 33.
    Kunz M, Bloss G, Gillitzer R, Gross G, Goebeler M, Rapp UR, Ludwig S: Hypoxia/reoxygenation induction of monocyte chemoattractant protein-1 in melanoma cells: involvement of nuclear factor-kB, stimulatory protein-1 transcription factor and mitogen-activated protein kinase pathway. Biochem J 366: 299–302, 2002PubMedGoogle Scholar
  34. 34.
    Huttunen M, Hyttinen M, Nilsson G, Butterfield JH, Horsmanheimo M, Harvima IT: Inhibition of keratinocyte growth in cell culture and whole skin culture by mast cell mediators. Exp Dermatol 10184–10192, 2001Google Scholar
  35. 35.
    Diegelmann RF, Evans MC: Wound healing: an overview of acute, fibrotic and delayed healing. Front Biosci 9: 283–289, 2004PubMedGoogle Scholar

Copyright information

© Springer Science + Business Media, Inc. 2005

Authors and Affiliations

  • Cacchio Marisa
    • 1
  • Isabella Lucci
    • 2
  • Camillo Di Giulio
    • 1
  • Giuseppina Bianchi
    • 1
  • Alfredo Grilli
    • 3
  • Antonia Patruno
    • 3
  • Marcella Reale
    • 2
  1. 1.Department of Biomedical SciencesUniversity “G. D’Annunzio”ChietiItaly
  2. 2.Department of Oncology and Neuroscience, Unit of ImmunologyUniversity “G. D’Annunzio”ChietiItaly
  3. 3.Department of Biomedical SciencesUniversity “G. D’Annunzio”ChietiItaly

Personalised recommendations